Filter by year

Edwards SAPIEN 3 TAVR Receives FDA Approval For Low-Risk Patients
Read story
Edwards Lifesciences Reports Second Quarter Results
Read story
Edwards Lifesciences To Host Earnings Conference Call On July 23, 2019
Read story
Edwards Comments On Updated TAVR National Coverage Determination
Read story
Edwards Lifesciences To Present At The Goldman Sachs 40th Annual Global Healthcare Conference
Read story